Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NQO1 | P15559 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9319930 | 0.92 | ACHE (0.43) | CYP3A4ALDH1A1KDM4ECA12CA1 | |
| SCHEMBL8994697 | 0.86 | TDP1 (0.48) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL29362051 | 0.85 | TDP1 (0.46) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11656824 | 0.83 | TDP1 (0.44) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL3536557 | 0.80 | TTR (0.55) | TDP1CYP3A4ALDH1A1HTTMAPT | |
| SCHEMBL28904235 | 0.79 | TDP1 (0.55) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL23081219 | 0.77 | HTR2C (0.37) | TDP1ALDH1A1KDM4EMAPTMEN1 | |
| SCHEMBL17472460 | 0.76 | KMT2A (0.46) | TDP1ALDH1A1KDM4ECA12CA9 | |
| SCHEMBL11791887 | 0.76 | ACHE (0.40) | CYP3A4ALDH1A1KDM4ECA12CA1 | |
| SCHEMBL29751099 | 0.74 | CA2 (0.52) | CYP3A4ALDH1A1KDM4ECA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9981978-B2 | Preparation of saturated ketone morphinan compounds by catalytic isomerisation | CAMBREX CHARLES CITY, INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-20160168159-A1 | PREPARATION OF SATURATED KETONE MORPHINAN COMPOUNDS BY CATALYTIC ISOMERISATION | CAMBREX CHARLES CITY, INC. | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168159-A1 | PREPARATION OF SATURATED KETONE MORPHINAN COMPOUNDS BY CATALYTIC ISOMERISATION | ADH1C, ADH1A, ADH5 | TDP1 2977/4885CYP3A4 30/4885ESR1 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.